121 related articles for article (PubMed ID: 15809166)
1. Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors.
Murineddu G; Ruiu S; Mussinu JM; Loriga G; Grella GE; Carai MA; Lazzari P; Pani L; Pinna GA
Bioorg Med Chem; 2005 May; 13(9):3309-20. PubMed ID: 15809166
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Lazzari P; Ruiu S; Sanna A; Loriga G; Manca I; Falzoi M; Dessì C; Curzu MM; Chelucci G; Pani L; Pinna GA
J Med Chem; 2006 Dec; 49(25):7502-12. PubMed ID: 17149879
[TBL] [Abstract][Full Text] [Related]
3. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
Deiana V; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Asproni B; Cichero E; Fossa P; Muñoz E; Deligia F; Murineddu G; García-Arencibia M; Pinna GA
Eur J Med Chem; 2016 Apr; 112():66-80. PubMed ID: 26890113
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic pyrazoles. Part 1: synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1and CB2 cannabinoid receptors.
Mussinu JM; Ruiu S; Mulè AC; Pau A; Carai MA; Loriga G; Murineddu G; Pinna GA
Bioorg Med Chem; 2003 Jan; 11(2):251-63. PubMed ID: 12470719
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
Pinna G; Loriga G; Lazzari P; Ruiu S; Falzoi M; Frau S; Pau A; Murineddu G; Asproni B; Pinna GA
Eur J Med Chem; 2014 Jul; 82():281-92. PubMed ID: 24922543
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB(1)) receptor ligands for potential use in molecular imaging.
Donohue SR; Halldin C; Pike VW
Bioorg Med Chem; 2006 Jun; 14(11):3712-20. PubMed ID: 16466922
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.
Silvestri R; Cascio MG; La Regina G; Piscitelli F; Lavecchia A; Brizzi A; Pasquini S; Botta M; Novellino E; Di Marzo V; Corelli F
J Med Chem; 2008 Mar; 51(6):1560-76. PubMed ID: 18293908
[TBL] [Abstract][Full Text] [Related]
10. A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives.
Lazzari P; Distinto R; Manca I; Baillie G; Murineddu G; Pira M; Falzoi M; Sani M; Morales P; Ross R; Zanda M; Jagerovic N; Pinna GA
Eur J Med Chem; 2016 Oct; 121():194-208. PubMed ID: 27240274
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716).
Francisco ME; Seltzman HH; Gilliam AF; Mitchell RA; Rider SL; Pertwee RG; Stevenson LA; Thomas BF
J Med Chem; 2002 Jun; 45(13):2708-19. PubMed ID: 12061874
[TBL] [Abstract][Full Text] [Related]
12. 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands.
Piscitelli F; Ligresti A; La Regina G; Gatti V; Brizzi A; Pasquini S; Allarà M; Carai MA; Novellino E; Colombo G; Di Marzo V; Corelli F; Silvestri R
Eur J Med Chem; 2011 Nov; 46(11):5641-53. PubMed ID: 21996466
[TBL] [Abstract][Full Text] [Related]
13. Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands.
Murineddu G; Asproni B; Corona P; Piras S; Lazzari P; Ruiu S; Legnani L; Toma L; Pinna GA
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035548
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of novel 4-alkyl-5-thien-2'-yl pyrazole carboxamides.
Lazzari P; Pau A; Tambaro S; Asproni B; Ruiu S; Pinna G; Mastinu A; Curzu MM; Reali R; Bottazzi ME; Pinna GA; Murineddu G
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):254-76. PubMed ID: 22931442
[TBL] [Abstract][Full Text] [Related]
15. Chromophore-modified bis-benzo[g]indole carboxamides: synthesis and antiproliferative activity of bis-benzo[g]indazole-3-carboxamides and related dimers.
Pinna GA; Pirisi MA; Mussinu JM; Murineddu G; Loriga G; Pau A; Grella GE
Farmaco; 2003 Sep; 58(9):749-63. PubMed ID: 13679168
[TBL] [Abstract][Full Text] [Related]
16. Tricyclic Pyrazoles. Part 5. Novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 Ligands Using Molecular Hybridization Based on Scaffold Hopping.
Murineddu G; Asproni B; Ruiu S; Deligia F; Falzoi M; Pau A; Thomas BF; Zhang Y; Pinna GA; Pani L; Lazzari P
Open Med Chem J; 2012; 6():1-14. PubMed ID: 22876271
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.
Lan R; Liu Q; Fan P; Lin S; Fernando SR; McCallion D; Pertwee R; Makriyannis A
J Med Chem; 1999 Feb; 42(4):769-76. PubMed ID: 10052983
[TBL] [Abstract][Full Text] [Related]
18. Conformationally restricted novel pyrazole derivatives: synthesis of 1,8-disubstituted 5,5-dimethyl-4,5-dihydro-1H-benzo[g]indazoles as a new class of PDE4 inhibitors.
Reddy TS; Kumar KS; Meda CL; Kandale A; Rambabu D; Krishna GR; Hariprasad C; Rao VV; Venkataiah S; Reddy CM; Naidu A; Dubey PK; Parsa KV; Pal M
Bioorg Med Chem Lett; 2012 May; 22(9):3248-55. PubMed ID: 22464134
[TBL] [Abstract][Full Text] [Related]
19. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817
[TBL] [Abstract][Full Text] [Related]
20. Pentacycle derivatives as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Lee SH; Ahn K; Lee M; Han HK; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6632-6. PubMed ID: 19850473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
